Track topics on Twitter Track topics that are important to you
Selexis is a privately held Swiss biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort, and costs required to develop and maintain high-performance mammalian cell lines used in the expression of pharmaceutically relevant proteins (i.e. targets, MAbs, rProteins). The company's core intellectual property portfolio is based on the discovery and application of novel DNA based elements that control the dynamic organization of chromatin within all mammalian cells - Selexis Genetic Elements(TM). Selexis has further developed platforms, to include: Selexis SUREtech Vectors(TM), Selexis SUREfection(TM) Selexis SURE Cell Line Development(TM) and Selexis INTEGRA-D2M(TM).
Will offer CDMO services by integrating its commercial subsidiary KBI Biopharma with Selexis
Switzerland-based biotech Selexis has signed a commercial license agreement that provides French firm…
JSR Life Sciences has acquired Swiss biotech Selexis for an undisclosed sum. The Geneva-headquartered company is the global leader in mammalian cell-line generation technologies and will boost JSR&rsq...
NewsJSR Life Sciences agrees to acquire pioneering cell line developer Selexis SA and integrate Selexis with KBI Biopharma, Inc.
Selexis SA has announced its cell line development laboratory will open this week in Geneva, Switzerland.
JSR Life Sciences is to acquire mammalian cell line development specialist Selexis, and integrate the Switzerland-based company with KBI Biopharma, the U.S.-based biopharma contract development and ma...
Try as we might, we can’t cover all the biotech news out there! Here’s a roundup of news that didn’t make the cut this week. Selexis was acquired by JSR Life Sciences, though terms were not disc...
Cell-line development specialist Selexis will be acquired by Japan-based JSR Life Sciences and will then be combined with KBI -More-
Selexis is a privately held Swiss biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort, and costs ...
Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...
July 2005Opening of the new R&D facility in Plan-les-OuatesSelexis is a private, Swiss-based biotechnology company leading the development of innovative solutions using proprietary technologies and ex...
Our ambition is to become a world leader in activation and regulation immunotherapies: OSE Immunotherapeutics is a biotechnology company led by world-class immunologists and focus...
We have published hundreds of Selexis SA news stories on BioPortfolio along with dozens of Selexis SA Clinical Trials and PubMed Articles about Selexis SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selexis SA Companies in our database. You can also find out about relevant Selexis SA Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...